Award recordCONTRACT

GILEAD SCIENCES INC

PIID 36C26125N0499· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2025· $14,894 net obligations· UEI FPJMGUK1BYH8· CA

Description

LENACAPAVIR (SUNLENCA)

First action · last action
2025-05-14 · 2025-05-14
Transactions
1
First transaction's obligation
$14,894
Base + all options value (sum of deltas)
$14,894
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70252
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$14,894$0Base award · 2025-05-14 · this action $14,894 · running total $14,894
  • Base2025-05-14+$14,894= $14,894
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-05-14+$14,894$14,894LENACAPAVIR (SUNLENCA)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FPJMGUK1BYH8)

AwardOffice · PSC / listingNet obligationsFY
36C26025F0137260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,103FY2025
36C26025F0134260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$2,482FY2025
36C24524N0911245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024
36C26024F0466260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C26024F0440260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C24524N0504245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26125N0499_3600_V797D70252_3600 · retrieved 2026-09-26.